Anti-inflammatory effect of plant compositions of Tibetan medicine in vitro on early rheumatoid arthritis

L. Yu. Semenova, J. M. Salmasi, G. V. Poryadin

.

DOI: 10.4236/health.2011.39096                

Abstract

Materials and Methods: lymphocytes of 10 pa-tients having early rheumatoid arthritis (RA) (the duration of the illness was 3 - 6 months) with a marked exudational process in joints were ex-amined. The content of lymphocytes expressing the CD3, CD4, CD8, CD16, CD56, CD20, CD72, CD38, CD23, CD25, CD71, HLA-DR, CD95, CD30, CD54, mIgM, mIgG antigens was determined. Results: the “Taban-Arshan” extract corrects the changes of the immune system characterized by the evident activation of the B-cell part of the immune system and normalizes immune parameters of the lymphocytes taken from the patients with autoimmune diseases (early rheumatoid arthritis). The immunocorrective effect of the “Taban-Arshan” extract is related to its ability to suppress the lymphocyte increased activation by normalizing expression of the main activation antigens (CD23, CD25, CD71, HLA-DR, CD54).

Keywords

Early Rheumatoid Arthritis; Subpopulation of Lymphocytes; Tibetan Medicine; Immunoregulators

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Proskuryakov, S.Y. and Gabai, VL. (2010) Mechanisms of tumor cell necrosis. Current Medicinal Chemistry, 16, 2010, 56-68. doi:10.2174/138161210789941793
[2]	Flad, H.D. and Brandt, E. (2010) Platelet-derived chemokines: Pathophysiology and therapeutic aspects. Cellular and Molecular Life Sciences, 7, 2010.
[3]	Stromberg, S.P. and Carlson, J.M. (2010) The suppression of immune system disorders by passive attrition. PLoS One, 5, 2010, 9648-9649.
[4]	Bach, J.F. (2005) Infections and autoimmune diseases. Journal of Autoimmunity, 25, 2005, 74-80. doi:10.1016/j.jaut.2005.09.024
[5]	Liu, Y., Dao, Z., Yang, C., Liu, Y. and Long, C. (2009) Medicinal plants used by Tibetans in Shangri-la, Yunnan, China. Journal of Ethnobiology and Ethnomedicine, 5, 2009, 15-16. doi:10.1186/1746-4269-5-15
[6]	Zhang, Z., Luo, P., Li, J., Yi, T., Wang, J., An, J. and Zhang, H. (2008) Comparison of the antiinflammatory activities of three medicinal plants known as “meiduoluomi” in Tibetan folk medicine. Yakugaku Zasshi, 128, 2008, 805-810. doi:10.1248/yakushi.128.805
[7]	Darshan, S. and Doreswamy, R. (2004) Patented antiinflammatory plant drug development from traditional medicine. Phytotherapy Research, 18, 2004, 343-357. doi:10.1002/ptr.1475
[8]	Talhouk, R.S., Karam, C., Fostok, S., El-Jouni, W. and Barbour, E.K. (2007) Anti-inflammatory bioactivities in plant extracts. Journal of Medicinal Food, 10, 2007, 1-10.
[9]	Olivo, E.L. (2009) Protection throughout the life span: The psychoneuroimmunologic impact of Indo-Tibetan meditative and yogic practices. The New York Academy of Sciences, 1172, 2009, 163-171. doi:10.1111/j.1749-6632.2009.04415.x
[10]	Badmaev, P.A. (1991) Fungamentals of the Tibetan medical science Chzhud-shi. Science.
[11]	Ayusheeva, L.V. (2006) Tibetan medicine in Buryatiya. Problems of Social Hygiene, Health Protection and History of Medicine, 5, 58-60.
[12]	Serebrennikova, Yu.A., Sakanyan, E.I., Каbyshev, K.E. and Sakanyan, K.М. (2005) Balneotherapy in today medical practice. Herald of VTU Series: Chemistry, Biology and Pharmacy, 1, 225-235.
[13]	Semenova, L.S., Sakanyan, E.I., Blinova, K.F., Bal’zhirov, B.G., Sambueva, Z.G., Merdygeeva, А.K., Moldaver, B.L. and Bartanov, А.I. (1997) “Taban-Arshan” phytopreparation for a balneal practice. Tibetan medicine. Traditions, perspectives, integration: Theses of reports on scientific-practice conference. Ulan-Ude, 80-82.
[14]	Korsun, V.F., Nikolarv, S.М., Dargaeva, Т.D., Rossiyskaya, G.I., Korsun, E.V. and Aleksandrov, Yu.N. (2004) Polyphytochol in therapy of liver diseases. Practical Phytotherapy, 3, 43-47.
[15]	Dashinamzhilov, Zh.B. (2008) Therapeutic effectiveness of “Polyphytochol” phytocollection in a complex therapy of alcohol damages of liver of patients with chronic alcoholism. Narcology Issues: Science and Practice, 4, 90-96.
[16]	Butov, М., Korsun, V., Korsun, Е. and Aleksandrov, Yu. (2005) Polyphytochol at functional disfunction of the biliary tract. Doctor, 1, 60-61.
[17]	Ubeeva, I.P., Ayusheva, S.Ts., Baldanov, B.V. and Zherbanova, L.V.(2007) An effect of “Baikalsky-7” phytocollection on chronic toxic hepatitis. Bulletin of the Eastern Siberian Scientific Center, 5, 54-56.
[18]	Potanin, A.Y., Timofeev, V.T., Shostak, N.A. and Anichkov, D.A. (2006) Phenotype of peripheral blood lymphocytes and serum immunoglobulin concentration in patients with early rheumatoid arthritis. Bulletin of Experimental Biology and Medicine, 141, 2006, 84-86.
[19]	Pincus, T. and Sokka, T. (2008) Mortality in rheumatic diseases: Introduction. Clinical and Experimental Rheumatology, 26, 35-61.
[20]	Miranda-Carús, M.E., Balsa, A., Benito-Miguel, M., Pérez de Ayala, C. and Martín-Mola, E. (2004) IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: Effect of methotrexate. The Journal of Immunology, 173, 2004, 1463-1476.
[21]	Ancu?a, C., Ancu?a, E., Iordache, C., Ceau?u, M. and Chirieac, R. (2009) Immunohistochemical study of skeletal muscle in rheumatoid myositis. Romanian Journal of Morphology and Embryology, 50, 2009, 223-227.
[22]	Shimojima, Y., Matsuda, M., Ishii, W., Gono, T. and Ikeda, S. (2008) Analysis of peripheral blood lymphocytes using flow cytometry in polymyalgia rheumatica, RS3PE and early rheumatoid arthritis. Clinical and Experimental Rheumatology, 26, 2008, 1079-1082.
[23]	Ria, F., Penitente, R,, De Santis, M., Nicolò, C., Di Sante, G., Orsini, M., Arzani, D., Fattorossi, A., Battaglia, A. and Ferraccioli, G.F. (2008) Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Research & Therapy, 10, 2008, R135. doi:10.1186/ar2553
[24]	Haas, C., Aicher, W.K., Dinkel, A., Peter, H.H. and Eibel, H. (1997) Characterization of SV40T antigen immortalized human synovial fibroblasts: Maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatology International, 16, 1997, 241-247. doi:10.1007/BF01375656
[25]	Galligan, C.L., Siebert, J.C., Siminovitch, K.A., Keystone, E.C., Bykerk, V., Perez, O.D. and Fish, E.N. (2009) Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: Implications for diagnosis and monitoring drug therapy. PLoS One, 20, 2009, 6703.
[26]	Klimiuk, P.A., Fiedorczyk, M., Sierakowski, S. and Chwiecko, J. (2007) Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scandinavian Journal of Rheumatology, 36, 2007, 345-350.
[27]	Montecucco, F., Burger, F., Pelli, G., Poku, N.K., Berlier, C., Steffens, S. and Mach, F. (2009) Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology, 48, 233-242. doi:10.1093/rheumatology/ken466
[28]	Lee, S.I., Lee, S.Y., Yoon, K.H., Choi, K.S., Jang, K.Y., Yoo, W.H., Kim, S.H., Choi, T.H. and Park, J.G. (1999) Molecular MR imaging for visualizing ICAM-1 expression in the inflamed synovium of collagen-induced arthritic mice. Korean Journal of Radiology, 10, 1999, 472-480. doi:10.3348/kjr.2009.10.5.472
[29]	Gerli, R., Bistoni, O., Lunardi, C., Giacomelli, R., Tomassini, C., Biagini, P. and Pitzalis, C. (1999) Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology, 38, 1999, 1282-1284. doi:10.1093/rheumatology/38.12.1282
[30]	Savolainen, E., Matinlauri, I., Kautiainen, H., Luosuj?rvi, R. and Kaipiainen-Sepp?nen, O. (2008) Serum soluble CD30 in early arthritis: A sign of inflammation but not a predictor of outcome. Clinical and Experimental Rheumatology, 26, 2008, 922-925.